Stock Price
0.45
Daily Change
-0.02 -3.23%
Monthly
-8.16%
Yearly
350.00%
Q1 Forecast
0.40

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025